Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

China Shenghuo Gets Opinion With Going Concern Qualification From Its Auditor

China Shenghuo Pharmaceutical Holdings, Inc. (KUN: Quote) said Friday that its audited consolidated financial statements for the fiscal year ended December 31, 2011, included in the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2012 contained a going concern qualification from its independent registered public accounting firm, Marcum Bernstein & Pinchuk LLP.

China Shenghuo is mainly engaged in the research, development, manufacture, and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty State Food and Drug Administration approved medicines, including the flagship product Xuesaitong Soft Capsules.

Click here to receive FREE breaking news email alerts for China Shenghuo Pharmaceutical Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
U.S. economic activity increased by more than expected in the third quarter of 2014, according to a report released by the Commerce Department on Thursday. The Commerce Department said GDP increased by 3.5 percent in the third quarter compared to 3.0 percent growth expected by economists. Germany's EU measure of inflation unexpectedly slowed in October after holding steady in the previous two months, preliminary estimates from Destatis showed Thursday. The harmonized index of consumer prices rose 0.7 percent annually following 0.8 percent increase in each of the previous three months.... First-time claims for U.S. unemployment benefits saw a modest increase in the week ended October 25th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims edged up to 287,000, an increase of 3,000 from the previous week's revised level of 284,000.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.